26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

400<br />

Chapter | 13 Hepatic Function<br />

cholestatic liver injury and in susceptibility to development<br />

<strong>of</strong> hepatocellular carcinoma ( Mauad et al., 1994 ). Finally,<br />

Mdr1 that is present in the canaliculus is responsible for<br />

transport <strong>of</strong> organic cations ( Trauner and Boyer, 2003 ).<br />

In cholestasis, bile acids may accumulate in hepatocytes<br />

and their toxicity may cause cell death ( Webster et al.,<br />

2002; Webster and Anwer, 1998, 2001 ). In cholestatic syndromes,<br />

expression <strong>of</strong> the multidrug resistance-associated<br />

protein 3 (Mrp3), another ABC transporter located in the<br />

sinusoidal plasma membrane, is increased. Mrp3 has broad<br />

affinity for organic anions, has the capacity to excrete both<br />

mono- and divalent bile acids ( Hirohashi et al., 2000 ; Ito<br />

et al., 2001 ), and is believed to compensate for impaired<br />

function <strong>of</strong> BSEP or Mrp2 in cholestatic syndromes<br />

( Bohan et al., 2003 ; Chen et al., 2007 ).<br />

In liver disease, synthesis <strong>of</strong> primary bile acids may be<br />

decreased, the proportions <strong>of</strong> cholic acid and chenodeoxycholic<br />

acid may be altered, or unusual bile acids may be<br />

produced. Removal <strong>of</strong> bile acids from the hepatic portal<br />

vein may be diminished by impaired hepatocellular function<br />

or by vascular shunts, which divert portal blood from<br />

the liver vasculature to the peripheral circulation. This is<br />

particularly noticeable after meals in animals with congenital<br />

or acquired hepatoportal shunts. The plasma bile acid<br />

concentration is increased continuously in biliary obstruction<br />

and, characteristically, urinary excretion <strong>of</strong> bile acids<br />

is increased. Increases in the serum bile acid concentration<br />

are seen in many forms <strong>of</strong> hepatic disease.<br />

The measurement <strong>of</strong> total serum bile acids for assessment<br />

<strong>of</strong> liver disease has been greatly facilitated by development<br />

<strong>of</strong> a spectrophotometric assay that has now been<br />

validated for use in most domestic species. The predictive<br />

value <strong>of</strong> the serum bile acid test is remarkably high in the<br />

dog ( Center, 1993 ; Center et al., 1984, 1991a ). In dogs with<br />

portocaval vascular shunts, the fasting serum bile acid concentration<br />

may be within normal limits but is increased diagnostically<br />

2 h following a meal (Center et al., 1985a ). Serum<br />

bile acid concentrations 20 μM/L in cats and 25 μm/L<br />

in dogs are predictive <strong>of</strong> significant histopathological abnormalities<br />

<strong>of</strong> the hepatobiliary system or <strong>of</strong> portosystemic vascular<br />

anastomoses ( Center et al., 1991a, 1995 ).<br />

The serum bile acid concentration has been used to<br />

assess clinical hepatic function in cattle ( Craig et al., 1992 ;<br />

Garry et al., 1994 ; Pearson et al., 1992 ; West, 1991 ) and<br />

in horses ( Barton and LeRoy, 2007 ; Durham et al., 2003 ;<br />

McGorum et al., 1999 ). In the horse, fasting alone has<br />

been reported to increase the plasma bile acid concentration<br />

by decreasing hepatic clearance ( Engelking and<br />

Gronwall, 1979 ), so in the horse it is necessary to consider<br />

food intake when interpreting the serum bile acid values.<br />

D . Serum Proteins<br />

The liver is the exclusive site <strong>of</strong> synthesis <strong>of</strong> albumin, the<br />

most abundant <strong>of</strong> the plasma proteins. Unlike most plasma<br />

proteins, which are glycoproteins, albumin contains no<br />

carbohydrate. Degradation <strong>of</strong> albumin occurs in the liver<br />

and in other tissues including muscle, kidney, and skin.<br />

Degradation <strong>of</strong> albumin is probably favored in the liver<br />

because <strong>of</strong> the fenestrated endothelial lining cells that<br />

allow access <strong>of</strong> plasma proteins directly to the space <strong>of</strong><br />

Disse and to the sinusoidal surface <strong>of</strong> the hepatocyte. In the<br />

general circulation, albumin has two major functions. It is<br />

the most important determinant <strong>of</strong> plasma oncotic pressure<br />

(colloid osmotic pressure) and is a major transport protein<br />

for hydrophobic or amphophilic metabolites and xenobiotics<br />

that, because <strong>of</strong> albumin binding, remain in stable aqueous<br />

solution in the plasma.<br />

The plasma albumin concentration is determined by<br />

the hepatic synthetic rate that normally is in equilibrium<br />

with degradation. Hypoalbuminemia may be caused by<br />

defective albumin synthesis associated with severe hepatocellular<br />

disease or may be caused by increased albumin<br />

loss resulting from either glomerulopathy (protein-losing<br />

nephropathy), severe intestinal inflammation, or intestinal<br />

lymphangiectasia (protein-losing enteropathy). In severe,<br />

chronic hepatopathy, there is a tendency for elevations in<br />

IgM, IgG, and IgA. Both decreased albumin and increased<br />

globulin result in a decrease in the albumin/globulin (A/G)<br />

ratio.<br />

The liver is the exclusive site <strong>of</strong> synthesis <strong>of</strong> coagulation<br />

factors I (fibrinogen), II (prothrombin), V, VII, IX, X,<br />

XI, and <strong>of</strong> protein C, protein S, and antithrombin. Factor<br />

VIII is synthesized both in the liver and in multiple other<br />

organs including the kidney and spleen ( Hollestelle et al.,<br />

2001 ; Wion et al., 1985 ). Synthesis <strong>of</strong> coagulation proteins<br />

tends to be diminished in liver disease, and decreased<br />

plasma prothrombin synthesis is associated with a corresponding<br />

increase in the prothrombin time. Factors that<br />

contribute to increased prothrombin time include diminished<br />

hepatic protein synthesis, increased consumption <strong>of</strong><br />

clotting factors associated with hemorrhage or hypercoagulation<br />

states, and, in some cases, vitamin K deficiency<br />

related to decreased intake or diminished absorption.<br />

Vitamin K is essential not only for the hepatic synthesis<br />

<strong>of</strong> prothrombin but also for factors VII, IX, X, and protein<br />

C. Parenteral administration <strong>of</strong> vitamin K to individual<br />

animal patients may result in improvement in prothrombin<br />

time, but coagulation time may remain prolonged.<br />

Individuals with obstructive jaundice absorb vitamin K<br />

poorly, and defects in their clotting tests can be improved<br />

rapidly by parenteral vitamin K administration. Fibrinogen<br />

is an acute phase reactant, and its concentration in plasma<br />

may be greatly increased in chronic inflammatory diseases<br />

or in neoplasia. Plasma fibrinogen is generally normal in<br />

mild or moderate liver disease, but it may be detectably<br />

decreased in more severe acute or chronic liver disease.<br />

Because <strong>of</strong> the rapid turnover <strong>of</strong> fibrinogen and prothrombin,<br />

the concentrations <strong>of</strong> these proteins in the plasma may<br />

decrease rapidly in fulminant hepatic injury. The turnover<br />

rate <strong>of</strong> albumin is longer and the concentration <strong>of</strong> albumin

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!